Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ovarian Neoplasms

  Free Subscription


Articles published in Anticancer Drugs

Retrieve available abstracts of 14 articles:
HTML format
Text format



Single Articles


    November 2019
  1. GUO Q, Yang Q, Li J, Liu G, et al
    Targeted therapy clinical trials in ovarian cancer: improved outcomes by gene mutation screening.
    Anticancer Drugs. 2019 Nov 15. doi: 10.1097/CAD.0000000000000858.
    PubMed     Text format     Abstract available


    September 2019
  2. MORI KM, Giuliano PD, Lopez KL, King MM, et al
    Pronounced clinical response following the oncolytic vaccinia virus GL-ONC1 and chemotherapy in a heavily pretreated ovarian cancer patient.
    Anticancer Drugs. 2019 Sep 16. doi: 10.1097/CAD.0000000000000836.
    PubMed     Text format     Abstract available


  3. HUANG YS, Wang TX, Lin XM, Wang H, et al
    Antitumor effect of a short peptide on p53-null SKOV3 ovarian cancer cells.
    Anticancer Drugs. 2019 Sep 9. doi: 10.1097/CAD.0000000000000830.
    PubMed     Text format     Abstract available


    July 2019
  4. VILLA M, Attianese D, Petracchini M, Ferrero A, et al
    Oral metronomic cyclophosphamide in advanced ovarian cancer: long-lasting clinical response in an elderly frailty patient.
    Anticancer Drugs. 2019 Jul 11. doi: 10.1097/CAD.0000000000000815.
    PubMed     Text format     Abstract available


    April 2019
  5. ROMERO I, Mallol P, Santaballa A, Del Campo JM, et al
    Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.
    Anticancer Drugs. 2019 Apr 18. doi: 10.1097/CAD.0000000000000794.
    PubMed     Text format     Abstract available


  6. LIU L, Liu P, Liang Z, Li R, et al
    Poly (ADP-ribose) polymerase inhibitors combined with other small-molecular compounds for the treatment of ovarian cancer.
    Anticancer Drugs. 2019 Apr 16. doi: 10.1097/CAD.0000000000000793.
    PubMed     Text format     Abstract available


    March 2019
  7. FAN M, Li C, He P, Fu Y, et al
    Knockdown of long noncoding RNA-taurine-upregulated gene 1 inhibits tumor angiogenesis in ovarian cancer by regulating leucine-rich alpha-2-glycoprotein-1.
    Anticancer Drugs. 2019 Mar 20. doi: 10.1097/CAD.0000000000000734.
    PubMed     Text format     Abstract available


    January 2019
  8. LIU Y, Zhou H, Yi T, Wang H, et al
    Pyrimethamine exerts significant antitumor effects on human ovarian cancer cells both in vitro and in vivo.
    Anticancer Drugs. 2019 Jan 5. doi: 10.1097/CAD.0000000000000740.
    PubMed     Text format     Abstract available


    September 2018
  9. SONG MM, Makena MR, Hindle A, Koneru B, et al
    Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
    Anticancer Drugs. 2018 Sep 27. doi: 10.1097/CAD.0000000000000696.
    PubMed     Text format     Abstract available


    November 2017
  10. LV KT, Gao LJ, Hua X, Li F, et al
    The role of the globular heads of the C1q receptor in paclitaxel-induced human ovarian cancer cells apoptosis by a mitochondria-dependent pathway.
    Anticancer Drugs. 2017 Nov 23. doi: 10.1097/CAD.0000000000000567.
    PubMed     Text format     Abstract available


    September 2017
  11. ASSI T, Kourie HR, El Rassy E, Moussa T, et al
    Response of an ovarian granulosa cell tumor with everolimus and exemestane after initial response to letrozole.
    Anticancer Drugs. 2017;28:931-933.
    PubMed     Text format     Abstract available


    August 2017
  12. REEVES PM, Abbaslou MA, Kools FRW, Poznansky MC, et al
    CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth.
    Anticancer Drugs. 2017 Aug 16. doi: 10.1097/CAD.0000000000000518.
    PubMed     Text format     Abstract available


    July 2017
  13. BORASKA JELAVIC T, Boban T, Brcic L, Vrdoljak E, et al
    Is macrocytosis a potential biomarker of the efficacy of dose-dense paclitaxel-carboplatin combination therapy in patients with epithelial ovarian cancer?
    Anticancer Drugs. 2017 Jul 3. doi: 10.1097/CAD.0000000000000538.
    PubMed     Text format     Abstract available


    May 2017
  14. PENDLEBURY A, DeBernardo R, Rose PG
    Long-term use of pegylated liposomal doxorubicin to a cumulative dose of 4600 mg/m2 in recurrent ovarian cancer.
    Anticancer Drugs. 2017 May 24. doi: 10.1097/CAD.0000000000000521.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: